[1] |
Reddy GKK, Padmavathi AR, Nancharaiah YV. Fungal infections: pathogenesis, antifungals and alternate treatment approaches[J]. Curr Res Microb Sci, 2022, 3: 100137.
|
[2] |
Page L, Wallstabe J, Lother J, et al. CcpA- and Shm2-pulsed myeloid dendritic cells induce T-cell activation and enhance the neutrophilic oxidative burst response to aspergillus fumigatus[J]. Front Immunol, 2021, 12: 659752.
doi: 10.3389/fimmu.2021.659752
|
[3] |
Mircescu MM, Lipuma L, van Rooijen N, et al. Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection[J]. J Infect Dis, 2009, 200(4): 647-656.
doi: 10.1086/600380
pmid: 19591573
|
[4] |
Stappers MHT, Clark AE, Aimanianda V, et al. Recognition of DHN-melanin by a C-type lectin receptor is required for immunity to Aspergillus[J]. Nature, 2018, 555(7696): 382-386.
doi: 10.1038/nature25974
|
[5] |
Dietschmann A, Schruefer S, Westermann S, et al. Phosphatidylinositol 3-kinase (PI3K) orchestrates aspergillus fumigatus-induced eosinophil activation independently of canonical toll-like receptor (TLR)/C-type-lectin receptor (CLR) signaling[J]. mBio, 2022, 13(4): e0123922.
|
[6] |
Chignard M, Balloy V, Sallenave JM, et al. Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts[J]. Clin Immunol, 2007, 124(3): 238-243.
doi: 10.1016/j.clim.2007.05.004
pmid: 17604224
|
[7] |
Zhang W, He D, Wei Y, et al. Suppression of aspergillus fumigatus germination by neutrophils is enhanced by endothelial-derived CSF3 production[J]. Front Microbiol, 2022, 13: 837776.
doi: 10.3389/fmicb.2022.837776
|
[8] |
Taylor PR, Roy S, Leal SM Jr, et al. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2[J]. Nat Immunol, 2014, 15(2): 143-151.
doi: 10.1038/ni.2797
pmid: 24362892
|
[9] |
Rudman J, Evans RJ, Johnston SA. Are macrophages the heroes or villains during cryptococcosis?[J]. Fungal Genet Biol, 2019, 132: 103261.
doi: 10.1016/j.fgb.2019.103261
|
[10] |
Zhang M, Sun D, Shi M. Dancing cheek to cheek: Cryptococcus neoformans and phagocytes[J]. Springerplus, 2015, 4: 410.
doi: 10.1186/s40064-015-1192-3
|
[11] |
Wang Y, Pawar S, Dutta O, et al. Macrophage mediated immunomodulation during cryptococcus pulmonary infection[J]. Front Cell Infect Microbiol, 2022, 12: 859049.
doi: 10.3389/fcimb.2022.859049
|
[12] |
Alshabani K, Haq A, Miyakawa R, et al. Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature[J]. Expert Rev Respir Med, 2015, 9(1): 89-96.
doi: 10.1586/17476348.2015.996132
|
[13] |
Crum-Cianflone NF. Invasive aspergillosis associated with severe influenza infections[J]. Open Forum Infect Dis, 2016, 3(3): ofw171.
|
[14] |
Tragiannidis A, Roilides E, Walsh TJ, et al. Invasive aspergillosis in children with acquired immunodeficiencies[J]. Clin Infect Dis, 2012, 54(2): 258-267.
doi: 10.1093/cid/cir786
pmid: 22075793
|
[15] |
Page ID, Richardson MD, Denning DW. Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA)[J]. J Infect, 2016, 72(2): 240-249.
doi: 10.1016/j.jinf.2015.11.003
pmid: 26680697
|
[16] |
Wardlaw AJ, Rick EM, Pur Ozyigit L, et al. New perspectives in the diagnosis and management of allergic fungal airway disease[J]. J Asthma Allergy, 2021, 14: 557-573.
doi: 10.2147/JAA.S251709
pmid: 34079294
|
[17] |
Singh M, Chauhan A, Paul N, et al. Need to re-look cut-off of Aspergillus-specific IgE levels in children with ABPA[J]. Mycoses, 2019, 62(9): 761-764.
doi: 10.1111/myc.12949
pmid: 31152616
|
[18] |
Toma P, Bertaina A, Castagnola E, et al. Fungal infections of the lung in children[J]. Pediatr Radiol, 2016, 46(13): 1856-1865.
pmid: 27663906
|
[19] |
Kassner EG, Kauffman SL, Yoon JJ, et al. Pulmonary candidiasis in infants: clinical, radiologic, and pathologic features[J]. AJR Am J Roentgenol, 1981, 137(4): 707-716.
doi: 10.2214/ajr.137.4.707
|
[20] |
Huang J, Lan C, Li H, et al. Concomitant lung adenocarcinoma and pulmonary cryptococcosis confirmed by pathologic examinations[J]. Medicine, 2019, 98(50): e18316.
|
[21] |
Yao K, Qiu X, Hu H, et al. Pulmonary cryptococcosis coexisting with central type lung cancer in an immuoc-ompetent patient: a case report and literature review[J]. BMC Pulm Med, 2020, 20(1): 161.
doi: 10.1186/s12890-020-01200-z
|
[22] |
Tobon AM, Gomez BL. Pulmonary histoplasmosis[J]. Mycopathologia, 2021, 186(5): 697-705.
doi: 10.1007/s11046-021-00588-4
pmid: 34498137
|
[23] |
Azar MM, Loyd JL, Relich RF, et al. Current concepts in the epidemiology, diagnosis, and management of histoplasmosis syndromes[J]. Semin Respir Crit Care Med, 2020, 41(1): 13-30.
doi: 10.1055/s-0039-1698429
pmid: 32000281
|
[24] |
Fischer GB, Mocelin H, Severo CB, et al. Histoplasmosis in children[J]. Paediatr Respir Rev, 2009, 10(4): 172-177.
doi: 10.1016/j.prrv.2009.08.002
pmid: 19879506
|
[25] |
Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis[J]. Clin Infect Dis, 2011, 53(5): 448-454.
doi: 10.1093/cid/cir435
pmid: 21810734
|
[26] |
Jude CM, Nayak NB, Patel MK, et al. Pulmonary coccidioidomycosis: pictorial review of chest radiographic and CT findings[J]. Radiographics, 2014, 34(4): 912-925.
doi: 10.1148/rg.344130134
pmid: 25019431
|
[27] |
Galgiani JN, Ampel NM, Blair JE, et al. Cocci-dioidomycosis[J]. Clin Infect Dis, 2005, 41(9): 1217-1223.
doi: 10.1086/496991
pmid: 16206093
|
[28] |
Rego de Figueiredo I, Vieira Alves R, Drummond Borges D, et al. Pneumocystosis pneumonia: a comparison study between HIV and non-HIV immunocompromised patients[J]. Pulmonology, 2019, 25(5): 271-274.
doi: S2531-0437(19)30087-X
pmid: 31076291
|